JSB Market Research: PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. See More: http://goo.gl/tW6DQL
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.
See More: http://goo.gl/tW6DQL
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Table 1: Genetic Fac<strong>to</strong>rs That Confer a Predisposition <strong>to</strong> UC 28<br />
Table 2: Typical Symp<strong>to</strong>ms of UC 30<br />
Table 3: Strongest Putative Risk Fac<strong>to</strong>rs for UC 34<br />
Table 4: Prevalence of UC in the US 39<br />
Table 5: Incidence of UC in the 5EU 40<br />
Table 6: Prevalence of UC in the 5EU 41<br />
Table 7: 10MM, Sources of UC Incidence Data Used in the Epidemiological<br />
<strong>Forecast</strong> 48<br />
Table 8: 10MM, Sources of UC Prevalence Data Used in the Epidemiological<br />
<strong>Forecast</strong> 49<br />
Table 9: 10MM, Incident Cases of UC, Ages ?10 Years, Both Sexes, N, Select Years,<br />
2012-<strong>2022</strong> 64<br />
Table 10: 10MM, Incident Cases of UC, By Age, Both Sexes, N (Row %), 2012 65<br />
Table 11: 10MM, Incident Cases of UC, By Sex, Ages ?10 Years, N (Row %), 2012<br />
67<br />
Table 12: 10MM, Prevalent Cases of UC, Ages ?10 Years, Both Sexes, N, Select<br />
Years, 2012-<strong>2022</strong> 71<br />
Table 13: 10MM, Prevalent Cases of UC, By Age, Both Sexes, N (Row %), 2012 73<br />
Table 14: 10MM, Prevalent Cases of UC, By Sex, Ages ?10 Years, N (Row %), 2012<br />
75<br />
Table 15: Truelove <strong>and</strong> Witts UC Severity Index 82<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language